在预测临床前实验室试验结果的基础上鉴定化合物的药理学性质

V. Loshmanov, A. Kravets
{"title":"在预测临床前实验室试验结果的基础上鉴定化合物的药理学性质","authors":"V. Loshmanov, A. Kravets","doi":"10.36807/1998-9849-2022-62-88-66-75","DOIUrl":null,"url":null,"abstract":"The method of determining the pharmacological properties of a chemical compound based on the prediction of the results of preclinical laboratory tests was presented. The results of preclinical trials are used to obtain information about the safety of the product under development both for the purposes of preclinical studies and throughout the entire drug cycle. The proposed approach makes it possible to determine the presence of specific pharmacological properties of chemicals in the compound intended for preclinical testing. The method includes conducting a factor analysis in order to identify the most significant features that affect the pharmacological activity of the observed synthesized chemical compound. Further, on the basis of the selected factors, a predictive model is built. The model uses data on the quantitative characteristics of the substance and a description of the target involved in the study. The developed approach essentially decreases the period of preclinical studies of new medicines","PeriodicalId":9467,"journal":{"name":"Bulletin of the Saint Petersburg State Institute of Technology (Technical University)","volume":"19 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"IDENTIFICATION OF THE PHARMACOLOGICAL PROPERTIES OF A CHEMICAL COMPOUND ON THE BASIS OF PREDICTING THE RESULTS OF PRECLINICAL LABORATORY TESTS\",\"authors\":\"V. Loshmanov, A. Kravets\",\"doi\":\"10.36807/1998-9849-2022-62-88-66-75\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The method of determining the pharmacological properties of a chemical compound based on the prediction of the results of preclinical laboratory tests was presented. The results of preclinical trials are used to obtain information about the safety of the product under development both for the purposes of preclinical studies and throughout the entire drug cycle. The proposed approach makes it possible to determine the presence of specific pharmacological properties of chemicals in the compound intended for preclinical testing. The method includes conducting a factor analysis in order to identify the most significant features that affect the pharmacological activity of the observed synthesized chemical compound. Further, on the basis of the selected factors, a predictive model is built. The model uses data on the quantitative characteristics of the substance and a description of the target involved in the study. The developed approach essentially decreases the period of preclinical studies of new medicines\",\"PeriodicalId\":9467,\"journal\":{\"name\":\"Bulletin of the Saint Petersburg State Institute of Technology (Technical University)\",\"volume\":\"19 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bulletin of the Saint Petersburg State Institute of Technology (Technical University)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.36807/1998-9849-2022-62-88-66-75\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bulletin of the Saint Petersburg State Institute of Technology (Technical University)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36807/1998-9849-2022-62-88-66-75","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

提出了一种根据临床前实验室试验结果的预测来确定化合物药理学性质的方法。临床前试验的结果用于获取正在开发的产品的安全性信息,用于临床前研究和整个药物周期。所提出的方法使得确定用于临床前测试的化合物中化学物质的特定药理学性质的存在成为可能。该方法包括进行因子分析,以确定影响所观察到的合成化合物的药理活性的最重要的特征。然后,在选取因子的基础上,建立预测模型。该模型使用有关物质的数量特征的数据和研究中涉及的目标的描述。开发的方法基本上缩短了新药临床前研究的时间
本文章由计算机程序翻译,如有差异,请以英文原文为准。
IDENTIFICATION OF THE PHARMACOLOGICAL PROPERTIES OF A CHEMICAL COMPOUND ON THE BASIS OF PREDICTING THE RESULTS OF PRECLINICAL LABORATORY TESTS
The method of determining the pharmacological properties of a chemical compound based on the prediction of the results of preclinical laboratory tests was presented. The results of preclinical trials are used to obtain information about the safety of the product under development both for the purposes of preclinical studies and throughout the entire drug cycle. The proposed approach makes it possible to determine the presence of specific pharmacological properties of chemicals in the compound intended for preclinical testing. The method includes conducting a factor analysis in order to identify the most significant features that affect the pharmacological activity of the observed synthesized chemical compound. Further, on the basis of the selected factors, a predictive model is built. The model uses data on the quantitative characteristics of the substance and a description of the target involved in the study. The developed approach essentially decreases the period of preclinical studies of new medicines
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信